XVIVO Q4 Initial take: Solid (Redeye)

2023-01-26 08:39
The most important aspects are organic growth and gross margins in our view. XVIVO delivers Q¤ organic growth of 27% well ahead of both out (+2%) and market expectations (+6). XVIVO also improves gross margins and delivers solid organic growth for all three business areas. We expect a positive initial market reaction of 3-5% and added support for the our structural XVIVO case.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

Xvivo Perfusion - I dag

{point.key}

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -